Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase NA 2Phase 2/3 2

Status

Unknown 2Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 83Lymphoid 80Breast 28Myeloid 16Sarcoma 8Head & Neck 8Genitourinary 5Classical hematology 5CNS 5Gynecologic 3Plasma cell 1Dermatologic 1

Conditions

Gestational Trophoblastic Disease 2Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 150Carboplatin 110Cisplatin 95Bevacizumab 42Topotecan 39Gemcitabine 38liposomal doxorubicin 34Radiotherapy 29Doxorubicin 27Brachytherapy 26Taxes 24pembrolizumab 20olaparib 20Drug Therapy 20Hyperthermic Intraperitoneal Chemotherapy 16Chemotherapy, Adjuvant 16human papillomavirus vaccine, L1 type 16, 18 15Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14Docetaxel 13Neoadjuvant Therapy 12Platinum 10niraparib 9Radiation 91,2-diaminocyclohexaneplatinum II citrate 9Vaccines, Synthetic 8Surgical Procedures, Operative 8atezolizumab 7Specimen Handling 7Papillomavirus Vaccines 7Letrozole 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Methotrexate × Gynecologic × Clear all
NCT03703271 2022-07-18

Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia

Women's Hospital School Of Medicine Zhejiang University

Phase 3 Unknown
214 enrolled
Gynecologic

Gestational Trophoblastic Disease

NCT02639650 2022-06-03

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

Women's Hospital School Of Medicine Zhejiang University

Phase 3 Unknown
214 enrolled
Gynecologic

Gestational Trophoblastic Disease

NCT00003209 2012-07-11

Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
700 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡